Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
24%
OVERLAP
BY WEIGHT
13
# OF OVERLAPPING
HOLDINGS
JDOC
70
HOLDINGS
22%
ALSO IN CANC
CANC
53
HOLDINGS
25%
ALSO IN JDOC
SECTOR DRIFT (JDOC minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in JDOC |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 8.4% | 5.0% | 5.0% |
 |
ASTRAZENECA PLC | 4.7% | 4.3% | 4.3% |
|
JOHNSON & JOHNSON | 4.9% | 3.0% | 3.0% |
|
ABBVIE INC | 6.6% | 2.8% | 2.8% |
|
MERCK & CO. INC. | 4.7% | 2.6% | 2.6% |
JDOC Overweight Relative to CANC
|
ABBVIE INC | 3.8% |
|
ELI LILLY & CO | 3.4% |
|
DANAHER CORP | 3.4% |
 |
MEDTRONIC PLC | 3.1% |
 |
ARGEN-X SE | 3.0% |
|
UNITEDHEALTH GROUP INC | 2.9% |
|
CVS CAREMARK CORP | 2.7% |
|
BOSTON SCIENTIFIC CORP | 2.5% |
 |
ROCHE HOLDING AG-BR | 2.5% |
 |
ESSILOR INTERNATIONAL | 2.4% |
JDOC Underweight Relative to CANC
|
REVOLUTION MEDICINES, INC. | -5.6% |
|
BRIDGEBIO PHARMA, INC. | -4.2% |
|
ROCHE HOLDINGS LTD-SPONS ADR | -3.8% |
|
COGENT BIOSCIENCES INC | -3.5% |
 |
GENMAB A/S SPONSORED ADR | -3.5% |
|
NUVALENT, INC. CLASS A | -3.4% |
|
EXELIXIS INC | -3.3% |
|
NOVARTIS AG | -3.1% |
|
BRISTOL-MYERS SQUIBB CO | -2.6% |
|
CELCUITY INC. | -2.5% |